Target intelligence / Profile preview

Histone H1.4 (H1.4)

Target
H1.4
Molecular classification
Histone protein, Linker histone, Chromatin architectural protein, Other
01

Overview

Histone H1.4 is a member of the linker histone H1 protein family, critical for chromatin structure in eukaryotic cells. Unlike core histones (H2A, H2B, H3, H4)—which create the nucleosome "bead"—H1.4 binds at the entry/exit points of DNA associated with the nucleosome and to the intervening linker DNA. This structural role enables H1.4 to mediate chromatin compaction from the “beads-on-a-string” form to a dense 30 nm fiber, influencing DNA accessibility for processes such as transcription, replication, and repair[1][2][3][4]. H1.4 consists of a conserved central globular domain and highly basic, flexible N- and C-terminal tails. These tails undergo extensive posttranslational modifications (PTMs), including methylation, acetylation, phosphorylation, and ubiquitination, which regulate the binding of effector proteins and impact chromatin states. Methylation of lysine 26 (K26) on H1.4 is particularly abundant and functions as a platform for proteins like HP1, important in heterochromatin formation and gene repression[2]. Histone H1.4, like other H1 variants, is multifunctional—regulating chromatin architecture, gene expression (primarily repression), nucleosome spacing, and facilitating the assembly or disassembly of chromatin in concert with histone chaperones and other protein partners[3]. In mammals, H1.4 is enriched in heterochromatin and less active genomic regions, in contrast to H1 variants found in actively transcribed regions. Although no drugs specifically target H1.4, its modifications—especially methylation and phosphorylation—are studied for their roles in cancer and other diseases, sometimes serving as biomarkers for pathological chromatin states[2]. Disturbed expression or modification of histone H1.4 can cause chromatin relaxation, genomic instability, and altered cell fate, making its indirect regulation a therapeutic concern, with potential risks tied to epigenetic therapies.

Other names
Histone H1.4H1F4HIST1H1EH1eH1s-4Histone H1bRMNSdJ221C16.5H1 histone family, member 4histone 1, H1ehistone cluster 1 H1 family member ehistone cluster 1, H1e
02

Mechanism of action

Not applicable (no direct drug targets; indirect actions include acetylation, methylation, phosphorylation affecting chromatin state)

03

Biological functions

Chromatin compactionNucleosome spacingTranscription regulationHigher-order chromatin structure stabilizationGene repressionHeterochromatin formationEmbryogenesisProtein–protein interactionsOther
04

Disease associations

CancerOther (Aberrant expression or modification has been linked to developmental disorders and cancer. Specifics on H1.4 are limited.)
05

Safety considerations

Chromatin disruption from altered H1.4 expression or modification can result in genomic instability, affecting cell growth, differentiation, and potentially promoting tumorigenesis[2][3]
06

Interacting drugs

None established (no approved drugs directly target Histone H1.4; histone-modifying agents act indirectly)
07

Biomarkers

Methylation status of lysine 26 on H1.4 (H1.4K26me, catalyzed by Ezh2/G9a and read by HP1/L3MBTL1, can be used as biomarker for heterochromatin state and certain cancers[2])

Beyond the preview

Go deeper on Histone H1.4 (H1.4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H1.4 (H1.4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call